Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies20
  • 7D-0.2%
  • 3M0.4%
  • 1Y55.0%
  • YTD24.7%

Over the last 7 days, the Healthcare industry has dropped 1.2%, driven by Novo Nordisk declining 0.6%. In the past year, the industry has gained 59%. As for the next few years, earnings are expected to grow by 14% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024DKK 4.5tDKK 355.4bDKK 106.3b35.7x42.4x12.7x
Sun, 23 Jun 2024DKK 4.9tDKK 355.4bDKK 106.2b34.5x46.6x13.9x
Tue, 21 May 2024DKK 4.6tDKK 355.3bDKK 106.2b37.8x43.2x12.9x
Thu, 18 Apr 2024DKK 4.5tDKK 341.3bDKK 99.6b33.9x44.7x13x
Sat, 16 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.3x46.5x13.6x
Mon, 12 Feb 2024DKK 4.3tDKK 340.5bDKK 98.6b33.1x43.3x12.6x
Wed, 10 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b34.1x41.7x11.7x
Fri, 08 Dec 2023DKK 3.5tDKK 320.5bDKK 90.0b33.1x38.7x10.9x
Sun, 05 Nov 2023DKK 3.5tDKK 318.7bDKK 90.3b29.1x39.2x11.1x
Tue, 03 Oct 2023DKK 3.4tDKK 305.6bDKK 82.2b32.8x41.4x11.1x
Thu, 31 Aug 2023DKK 3.4tDKK 305.2bDKK 82.1b35.9x41.6x11.2x
Sat, 29 Jul 2023DKK 2.9tDKK 287.1bDKK 75.5b37.2x38.5x10.1x
Mon, 26 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b39.9x39.7x10.4x
Wed, 24 May 2023DKK 3.1tDKK 287.1bDKK 75.5b41.9x41.7x10.9x
Fri, 21 Apr 2023DKK 3.1tDKK 272.6bDKK 68.5b43.6x45.1x11.3x
Sun, 19 Mar 2023DKK 2.7tDKK 292.6bDKK 69.2b37.6x39.6x9.4x
Tue, 14 Feb 2023DKK 2.8tDKK 289.4bDKK 68.9b40.2x40.5x9.6x
Thu, 12 Jan 2023DKK 2.6tDKK 276.0bDKK 66.3b37.7x39.4x9.5x
Sat, 10 Dec 2022DKK 2.7tDKK 276.1bDKK 66.3b38.5x40.2x9.7x
Mon, 07 Nov 2022DKK 2.5tDKK 271.2bDKK 64.6b36x38x9.1x
Wed, 05 Oct 2022DKK 2.3tDKK 261.2bDKK 62.4b35.2x36.9x8.8x
Fri, 02 Sep 2022DKK 2.3tDKK 260.4bDKK 62.4b34.7x36.8x8.8x
Sun, 31 Jul 2022DKK 2.5tDKK 247.8bDKK 59.9b38x42.2x10.2x
Tue, 28 Jun 2022DKK 2.4tDKK 247.6bDKK 59.9b36.6x39.4x9.5x
Thu, 26 May 2022DKK 2.2tDKK 247.6bDKK 59.7b34x37.1x8.9x
Sat, 23 Apr 2022DKK 2.4tDKK 238.1bDKK 59.8b38.1x39.7x10x
Mon, 21 Mar 2022DKK 2.3tDKK 237.9bDKK 59.8b39.5x38.6x9.7x
Wed, 16 Feb 2022DKK 2.1tDKK 236.9bDKK 59.3b38.2x35.7x8.9x
Fri, 14 Jan 2022DKK 2.1tDKK 229.2bDKK 57.8b48.2x36.9x9.3x
Sun, 12 Dec 2021DKK 2.4tDKK 229.2bDKK 57.8b52.3x41.6x10.5x
Tue, 09 Nov 2021DKK 2.4tDKK 228.7bDKK 57.5b55.5x42.2x10.6x
Thu, 07 Oct 2021DKK 2.1tDKK 223.3bDKK 55.6b60.3x37.5x9.3x
Sat, 04 Sep 2021DKK 2.2tDKK 223.2bDKK 55.6b69.7x40.1x10x
Mon, 02 Aug 2021DKK 2.1tDKK 223.2bDKK 55.6b65.6x38.2x9.5x
Price to Earnings Ratio

38.2x


Total Market Cap: DKK 2.1tTotal Earnings: DKK 55.6bTotal Revenue: DKK 223.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 40.6x202220232024
Current Industry PE
  • Investors are relatively neutral on the Danish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 40.6x.
  • The 3-year average PS ratio of 10.6x is lower than the industry's current PS ratio of 12.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.34%
Healthcare-0.20%
Biotech5.05%
Medical Equipment1.81%
Healthtech1.28%
Pharma-0.59%
Healthcare Services-4.61%
Life Sciences-5.62%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 445x.
    • Analysts are expecting annual earnings growth of 59.4% and investors are willing to pay a premium for that growth.
  • Investors are most pessimistic about the Healthcare Services industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 18.7x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 59% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
COLO B ColoplastDKK 893.403.2%
+DKK 6.3b		5.8%PE40.5x
ZEAL Zealand PharmaDKK 932.509.7%
+DKK 5.8b		323.5%PS191.4x
GMAB GenmabDKK 1.93k4.1%
+DKK 4.8b		-28.4%PE22.4x
HLUN B H. LundbeckDKK 41.003.4%
+DKK 1.3b		24.2%PE16.8x
EMBLA Embla Medical hfDKK 30.806.2%
+DKK 768.5m		-5.8%PE31.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

EMBLA

DKK 30.80

Embla Medical hf

7D

6.2%

1Y

-5.8%

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

DEMANT

DKK 252.00

Demant

7D

-2.7%

1Y

-8.3%

BAVA

DKK 185.10

Bavarian Nordic

7D

-1.2%

1Y

30.2%

GMAB

DKK 1,926.50

Genmab

7D

4.1%

1Y

-28.4%

COLO B

DKK 893.40

Coloplast

7D

3.2%

1Y

5.8%

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

NOVO B

DKK 881.60

Novo Nordisk

7D

-0.6%

1Y

65.7%

GUBRA

DKK 564.00

Gubra

7D

-6.9%

1Y

500.1%

CHEMM

DKK 374.00

ChemoMetec

7D

-3.7%

1Y

-17.7%

HLUN B

DKK 41.00

H. Lundbeck

7D

3.4%

1Y

24.2%

Investors Interested In H. Lundbeck A/S' (CPH:HLUN B) Earnings

Jul 01
Investors Interested In H. Lundbeck A/S' (CPH:HLUN B) Earnings

ZEAL

DKK 932.50

Zealand Pharma

7D

9.7%

1Y

323.5%

BIOPOR

DKK 2.22

BioPorto

7D

-0.7%

1Y

80.5%

ALK B

DKK 149.80

ALK-Abelló

7D

-2.5%

1Y

107.8%

Is ALK-Abelló (CPH:ALK B) Using Too Much Debt?

Jun 25
Is ALK-Abelló (CPH:ALK B) Using Too Much Debt?

AMBU B

DKK 135.60

Ambu

7D

0.3%

1Y

30.1%

NNIT

DKK 107.80

NNIT

7D

0.9%

1Y

33.7%

SMSMED

DKK 5.80

Scandinavian Medical Solutions

7D

-4.6%

1Y

-47.3%

MONSO

DKK 0.59

Monsenso

7D

31.6%

1Y

47.6%